ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Malaysia's Khazanah sells shares of genetics screening MGRC

Sovereign wealth fund lets go of 11% stake in ACE Market-listed company

Malaysia's Prime Minister Muhyiddin Yassin is the chairman of sovereign wealth fund Khazanah Nasional Bhd.   © Reuters

KUALA LUMPUR -- Malaysian sovereign wealth fund Khazanah Nasional Bhd has ceased to be a substantial shareholder in genetics screening company Malaysian Genomics Resource Centre Bhd (MGRC) after a recent share sale.

The development comes after Khazanah sold 12 million shares, an 11.59% stake, through indirect subsidiary Synamatix Sdn Bhd, according to a bourse filing on May 15.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more